Published on
April 19, 2018
- 12:30 GMT
Onconova Presents Data on Dual Inhibitor of CDK4/6 + ARK5 at American Association for Cancer Research 2018 Annual Meeting
Onconova receives productive pre-IND guidance from FDA regarding first-in-class compound ON 123300 Preclinical data reveals differential metabolism of ON 123300 in male versus female rodents, with implications for development of dosing strategy Development …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
